NewAmsterdam Pharma

NAMS · NASDAQ🇳🇱

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

Previous year: -$1.06

-67.9%

Research and Development Expenses

$44.8M

Previous year: $42.4M

+5.5%

Selling, General and Administrative Expenses

$27.2M

Previous year: $14.5M

+87.9%

Total Operating Expenses

$71.9M

Previous year: $56.9M

Loading...

NewAmsterdam Pharma

Unlock previous datapoints

Upgrade

NewAmsterdam Pharma

Unlock previous datapoints

Upgrade

NewAmsterdam Pharma Revenue by Geographic Location

Revenue by Geographic Location

Italy Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.79B

P/E Ratio

-16.20

Sector

N/A

Industry

N/A

52-Week High

$41.4

52-Week Low

$14.9

Research and Development Expenses

$44.8M

Selling, General and Administrative Expenses

$27.2M

Total Operating Expenses

$71.9M

Net Loss

-$39.5M

Marketable Securities

$60.1M

Products

Get in Touch

Resources

NewAmsterdam Pharma

NewAmsterdam Pharma

NewAmsterdam Pharma

NewAmsterdam Pharma Revenue by Geographic Location

Revenue by Geographic Location

Italy Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics